Efficacy of prophylactic application of immunoglobulins in radiation induced mucositis.
Mose
S
S
Abteilung für Strahlentherapie und Onkologie, Zentrum der Radiologie, Johann-Wolfgang-Goethe-Universität, Frankfurt.
Adamietz
I A
IA
Saran
F
F
Thilmann
C
C
Heyd
R
R
Böttcher
H D
HD
D016190:Carboplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D004334:Drug Administration Schedule; D006258:Head and Neck Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D006801:Humans; D007136:Immunoglobulins / Q000008:administration & dosage*; D007273:Injections, Intramuscular; D009092:Mucous Membrane / Q000528:radiation effects*; D009761:Nystatin / Q000627:therapeutic use; D010205:Pantothenic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D011832:Radiation Injuries / Q000517:prevention & control*; D011878:Radiotherapy / Q000009:adverse effects*; D011879:Radiotherapy Dosage
D007136:Immunoglobulins; D009761:Nystatin; D010205:Pantothenic Acid; C007288:dexpanthenol; D016190:Carboplatin